Connection

Erin Weeda to Humans

Back to Details
This is a "connection" page, showing publications Erin Weeda has written about Humans.
Erin Weeda
Connection Strength
0.926
Humans
  1. Social Determinants of Health in U.S. Counties Where Guideline-Influencing Diabetes Studies Were Conducted. Diabetes Care. 2022 05 01; 45(5):e87-e88.
    View in: PubMed
    Score: 0.031
  2. Disparity in the rural-urban distribution of clinical trial sites used in studies cited by diabetes treatment guidelines. Diabetes Obes Metab. 2022 03; 24(3):561-563.
    View in: PubMed
    Score: 0.030
  3. Advice Provided by a Pharmacy Residency Research Committee. Ann Pharmacother. 2021 12; 55(12):1547-1549.
    View in: PubMed
    Score: 0.029
  4. Medication adherence to injectable glucagon-like peptide-1 (GLP-1) receptor agonists dosed once weekly vs once daily in patients with type 2 diabetes: A meta-analysis. Int J Clin Pract. 2021 Sep; 75(9):e14060.
    View in: PubMed
    Score: 0.028
  5. Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study. BMC Cardiovasc Disord. 2020 10 15; 20(1):449.
    View in: PubMed
    Score: 0.028
  6. Influence of hospital encounters for falls on potentially inappropriate medication use among older patients. Geriatr Gerontol Int. 2020 Aug; 20(8):795-796.
    View in: PubMed
    Score: 0.027
  7. Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis. J Thromb Thrombolysis. 2020 Apr; 49(3):360-364.
    View in: PubMed
    Score: 0.027
  8. Impact of Race and Location of Residence on Statin Treatment Among Veterans With Type 2 Diabetes Mellitus. Am J Cardiol. 2020 05 15; 125(10):1492-1499.
    View in: PubMed
    Score: 0.026
  9. Costs and factors associated with heart failure following kidney transplantation - a single-center retrospective cohort study. Transpl Int. 2020 04; 33(4):414-422.
    View in: PubMed
    Score: 0.026
  10. Loop diuretic use among patients with heart failure and type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors. J Diabetes Complications. 2019 08; 33(8):567-571.
    View in: PubMed
    Score: 0.025
  11. Hospital admissions and emergency department visits among kidney transplant recipients. Clin Transplant. 2019 05; 33(5):e13522.
    View in: PubMed
    Score: 0.025
  12. Saddle pulmonary embolism and in-hospital mortality in patients with cancer. Int J Clin Oncol. 2019 Jun; 24(6):727-730.
    View in: PubMed
    Score: 0.025
  13. Comorbid cancer and use of thrombolysis in acute pulmonary embolism. J Thromb Thrombolysis. 2019 Feb; 47(2):324-327.
    View in: PubMed
    Score: 0.024
  14. Systematic Review of Real-World Studies Evaluating Characteristics Associated With or Programs Designed to Facilitate Outpatient Management of Deep Vein Thrombosis. Clin Appl Thromb Hemost. 2018 Dec; 24(9_suppl):301S-313S.
    View in: PubMed
    Score: 0.024
  15. Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life. Int J Cardiol. 2018 Dec 15; 273:34-38.
    View in: PubMed
    Score: 0.024
  16. External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer. Support Care Cancer. 2019 Mar; 27(3):921-925.
    View in: PubMed
    Score: 0.024
  17. Association between comorbid cancer and outcomes among admissions for acute ischemic stroke receiving systemic thrombolysis. Int J Stroke. 2019 01; 14(1):48-52.
    View in: PubMed
    Score: 0.023
  18. External Validation of Generic and Cancer-Specific Risk Stratification Tools in Patients With Pulmonary Embolism and Active Cancer. J Natl Compr Canc Netw. 2017 12; 15(12):1476-1482.
    View in: PubMed
    Score: 0.023
  19. Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk. J Diabetes Complications. 2018 02; 32(2):210-215.
    View in: PubMed
    Score: 0.022
  20. Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status. Int J Clin Pract. 2017 Jan; 71(1).
    View in: PubMed
    Score: 0.021
  21. Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism. J Thromb Thrombolysis. 2016 Nov; 42(4):513-9.
    View in: PubMed
    Score: 0.021
  22. Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin. Intern Emerg Med. 2017 Apr; 12(3):311-318.
    View in: PubMed
    Score: 0.021
  23. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism. Pharmacotherapy. 2016 10; 36(10):1109-1115.
    View in: PubMed
    Score: 0.021
  24. Association between weekend admission and mortality for upper gastrointestinal hemorrhage: an observational study and meta-analysis. Intern Emerg Med. 2017 Mar; 12(2):163-169.
    View in: PubMed
    Score: 0.021
  25. Outcomes associated with observation status versus inpatient management of pulmonary embolism patients anticoagulated with rivaroxaban. Int J Cardiol. 2016 Nov 01; 222:846-849.
    View in: PubMed
    Score: 0.021
  26. External Validation of the Hestia Criteria for Identifying Acute Pulmonary Embolism Patients at Low Risk of Early Mortality. Clin Appl Thromb Hemost. 2017 Oct; 23(7):769-774.
    View in: PubMed
    Score: 0.020
  27. Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis. Int J Cardiol. 2016 Aug 01; 216:104-9.
    View in: PubMed
    Score: 0.020
  28. Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis. Curr Med Res Opin. 2016 06; 32(6):1117-20.
    View in: PubMed
    Score: 0.020
  29. Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease. Ann Pharmacother. 2016 06; 50(6):475-85.
    View in: PubMed
    Score: 0.020
  30. Association between weekend admission for atrial fibrillation or flutter and in-hospital mortality, procedure utilization, length-of-stay and treatment costs. Int J Cardiol. 2016 Jan 01; 202:427-9.
    View in: PubMed
    Score: 0.019
  31. Trends in prescribing as-needed inhaled corticosteroid (ICS)-Formoterol for patients with asthma. Respir Med. 2023 02; 207:107096.
    View in: PubMed
    Score: 0.008
  32. Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant. J Oncol Pharm Pract. 2022 Oct; 28(7):1613-1616.
    View in: PubMed
    Score: 0.008
  33. Clinical utility of negative methicillin-resistant Staphylococcus aureus (MRSA) nasal surveillance swabs in skin and skin structure infections. Am J Infect Control. 2022 08; 50(8):941-946.
    View in: PubMed
    Score: 0.007
  34. The Magnitude and Potential Causes of Sex Disparities in Statin Therapy in Veterans with Type 2 Diabetes: A 10-year Nationwide Longitudinal Cohort Study. Womens Health Issues. 2022 May-Jun; 32(3):274-283.
    View in: PubMed
    Score: 0.007
  35. A Dialysis Center Educational Video Intervention Increases Patient Self-Efficacy and Kidney Transplant Evaluations. Prog Transplant. 2022 03; 32(1):27-34.
    View in: PubMed
    Score: 0.007
  36. Effectiveness and Safety of Twice- Versus Thrice-Daily Subcutaneous Heparin for Venous Thromboembolism Prophylaxis at a Large Academic Medical Center. Ann Pharmacother. 2022 05; 56(5):541-547.
    View in: PubMed
    Score: 0.007
  37. Association of High Burden of End-stage Kidney Disease With Decreased Kidney Transplant Rates With the Updated US Kidney Allocation Policy. JAMA Surg. 2021 07 01; 156(7):639-645.
    View in: PubMed
    Score: 0.007
  38. An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems. J Manag Care Spec Pharm. 2020 Sep; 26(9):1090-1098.
    View in: PubMed
    Score: 0.007
  39. Intravenous insulin for the management of non-emergent hyperglycemia in the emergency department. Am J Emerg Med. 2021 07; 45:335-339.
    View in: PubMed
    Score: 0.007
  40. Association Between Potentially Inappropriate Medications and Hospital Encounters Among Older Adults: A Meta-Analysis. Drugs Aging. 2020 07; 37(7):529-537.
    View in: PubMed
    Score: 0.007
  41. Weight-based versus non-weight-based diltiazem dosing in the setting of atrial fibrillation with rapid ventricular response. Am J Emerg Med. 2020 11; 38(11):2271-2276.
    View in: PubMed
    Score: 0.006
  42. Cabozantinib use in metastatic renal cell carcinoma patients in clinical practice: Evaluation of dosing patterns, tolerability, and outcomes compared to clinical trials. J Oncol Pharm Pract. 2020 Jun; 26(4):861-865.
    View in: PubMed
    Score: 0.006
  43. Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria. Diabet Med. 2020 01; 37(1):44-52.
    View in: PubMed
    Score: 0.006
  44. Impact of De-Identification on Clinical Text Classification Using Traditional and Deep Learning Classifiers. Stud Health Technol Inform. 2019 Aug 21; 264:283-287.
    View in: PubMed
    Score: 0.006
  45. Automated detection of altered mental status in emergency department clinical notes: a deep learning approach. BMC Med Inform Decis Mak. 2019 08 19; 19(1):164.
    View in: PubMed
    Score: 0.006
  46. Outcomes Associated With the Adjunctive Use of Dipeptidyl Peptidase-4 Inhibitors With Insulin Versus Other Antihyperglycemic Medications in Patients With Prediabetes or Diabetes After Cardiac Surgery. J Pharm Pract. 2021 Apr; 34(2):259-264.
    View in: PubMed
    Score: 0.006
  47. Assessment of intravenous insulin dosing strategies for the treatment of acute hyperkalemia in the emergency department. Am J Emerg Med. 2020 06; 38(6):1082-1085.
    View in: PubMed
    Score: 0.006
  48. Antibiotic Use and Respiratory Pathogens in Adults With Sickle Cell Disease and Acute Chest Syndrome. Ann Pharmacother. 2019 10; 53(10):991-996.
    View in: PubMed
    Score: 0.006
  49. Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin. Neurocrit Care. 2019 04; 30(2):301-306.
    View in: PubMed
    Score: 0.006
  50. Impact of a co-curricular, e-learning activity on pharmacy student knowledge of laboratory values. Curr Pharm Teach Learn. 2019 01; 11(1):87-93.
    View in: PubMed
    Score: 0.006
  51. Effectiveness and safety of rivaroxaban vs. warfarin in patients 80+ years of age with non-valvular atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2018 10 01; 4(4):328-329.
    View in: PubMed
    Score: 0.006
  52. Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis. JAMA. 2018 04 10; 319(14):1473-1484.
    View in: PubMed
    Score: 0.006
  53. Association of Inhaled Corticosteroids and Long-Acting ?-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis. JAMA. 2018 04 10; 319(14):1485-1496.
    View in: PubMed
    Score: 0.006
  54. Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients. Clin Cardiol. 2018 Jan; 41(1):119-125.
    View in: PubMed
    Score: 0.006
  55. Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta-analysis. J Thromb Haemost. 2018 02; 16(2):279-292.
    View in: PubMed
    Score: 0.006
  56. Should an LDL-Cholesterol Target-Based Approach Be Readopted? Ann Pharmacother. 2018 02; 52(2):175-184.
    View in: PubMed
    Score: 0.006
  57. Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis. BMC Pulm Med. 2017 Feb 13; 17(1):37.
    View in: PubMed
    Score: 0.005
  58. External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans. Intern Emerg Med. 2017 Aug; 12(5):613-619.
    View in: PubMed
    Score: 0.005
  59. External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications. BMC Health Serv Res. 2016 10 22; 16(1):610.
    View in: PubMed
    Score: 0.005
  60. Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism? Clin Appl Thromb Hemost. 2017 Oct; 23(7):830-837.
    View in: PubMed
    Score: 0.005
  61. Outcomes related to variation in hospital pulmonary embolus observation stay utilization. Hosp Pract (1995). 2016 Aug; 44(3):133-7.
    View in: PubMed
    Score: 0.005
  62. Impact of non-medical switching on clinical and economic outcomes, resource utilization and medication-taking behavior: a systematic literature review. Curr Med Res Opin. 2016 07; 32(7):1281-90.
    View in: PubMed
    Score: 0.005
  63. Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination. Thromb Res. 2016 May; 141:8-10.
    View in: PubMed
    Score: 0.005
  64. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction. J Clin Pharmacol. 2016 08; 56(8):936-47.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.